Esp34 Inhibitors
Esp34 Inhibitors: A Complex Regulatory Network Unveiled
The chemical class known as Esp34 Inhibitors encompasses a diverse array of compounds that can potentially modulate the activity of Esp34, encoded by the Esp34 gene. Esp34 plays a crucial role in cellular processes, and its activity can be influenced by various signaling pathways.
GW501516, a PPAR-δ agonist, may activate Esp34 by binding to PPAR-δ and modulating gene expression. Forskolin increases cAMP levels, potentially activating Esp34 through downstream signaling pathways associated with cAMP. Rosiglitazone, a PPAR-γ agonist, can modulate Esp34 by activating PPAR-γ and influencing associated cellular processes.
SB203580, a p38 MAPK inhibitor, may activate Esp34 by preventing its phosphorylation and impacting downstream signaling pathways. A-769662, an AMPK activator, can potentially activate Esp34 by stimulating AMPK and modulating cellular energy homeostasis. PD98059, a MEK inhibitor, may activate Esp34 by preventing its phosphorylation and influencing downstream signaling pathways.
5-Azacytidine, a demethylating agent, can activate Esp34 by influencing DNA methylation patterns and altering gene expression. Y-27632, a ROCK inhibitor, may activate Esp34 by modulating Rho GTPase signaling and downstream processes. Bay 11-7082, an NF-κB inhibitor, may activate Esp34 by preventing its regulation through NF-κB signaling pathways.
STO-609, a CaMKK inhibitor, may activate Esp34 by preventing its phosphorylation and modulating downstream signaling pathways. BAY 61-3606, a Syk tyrosine kinase inhibitor, can activate Esp34 by preventing its phosphorylation and influencing downstream signaling pathways. GSK-650394, a p38α MAPK inhibitor, may activate Esp34 by preventing its phosphorylation and modulating downstream signaling cascades.
The intricate interplay between these inhibitors and Esp34 highlights the complexity of the regulatory network governing this protein's activity. The diverse mechanisms through which these compounds exert their effects on Esp34 underscore the multifaceted nature of cellular signaling pathways and the potential for targeted modulation within this intricate system. Understanding the intricacies of Esp34 regulation opens avenues for further exploration into the broader landscape of cellular processes and their modulation for potential applications in research and development.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
GW501516 | 317318-70-0 | sc-202642 sc-202642A | 1 mg 5 mg | $82.00 $179.00 | 28 | |
GW501516, also known as Cardarine, is a peroxisome proliferator-activated receptor-delta (PPAR-δ) agonist. It can potentially activate Esp34 by binding to PPAR-δ, leading to the modulation of gene expression and cellular processes associated with Esp34 activation. | ||||||
Rosiglitazone | 122320-73-4 | sc-202795 sc-202795A sc-202795C sc-202795D sc-202795B | 25 mg 100 mg 500 mg 1 g 5 g | $120.00 $326.00 $634.00 $947.00 $1259.00 | 38 | |
Rosiglitazone is a thiazolidinedione and a selective agonist for peroxisome proliferator-activated receptor-gamma (PPAR-γ). By activating PPAR-γ, rosiglitazone can potentially modulate Esp34 activity through the regulation of gene expression and cellular processes associated with PPAR-γ activation. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
SB203580 is a selective inhibitor of p38 mitogen-activated protein kinase (MAPK). Inhibition of p38 MAPK may activate Esp34 by preventing its phosphorylation and modulating downstream signaling pathways. This impact on intracellular signaling cascades can contribute to Esp34 activation. | ||||||
A-769662 | 844499-71-4 | sc-203790 sc-203790A sc-203790B sc-203790C sc-203790D | 10 mg 50 mg 100 mg 500 mg 1 g | $184.00 $741.00 $1076.00 $3417.00 $5304.00 | 23 | |
A-769662 is an AMP-activated protein kinase (AMPK) activator. It can potentially activate Esp34 by stimulating AMPK, leading to the modulation of cellular energy homeostasis and influencing downstream processes associated with AMPK activation, contributing to Esp34 activation. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
PD98059 is a selective inhibitor of mitogen-activated protein kinase kinase (MEK). Inhibition of MEK may activate Esp34 by preventing its phosphorylation and influencing downstream signaling pathways. This modulation of intracellular signaling cascades can contribute to Esp34 activation. | ||||||
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
5-Azacytidine is a demethylating agent that can activate Esp34 by influencing DNA methylation patterns. Changes in DNA methylation may lead to alterations in gene expression and cellular processes associated with Esp34 activation, contributing to its activation. | ||||||
Y-27632, free base | 146986-50-7 | sc-3536 sc-3536A | 5 mg 50 mg | $186.00 $707.00 | 88 | |
Y-27632 is a selective inhibitor of Rho-associated protein kinase (ROCK). Inhibition of ROCK may activate Esp34 by influencing Rho GTPase signaling and downstream processes. Modulation of these signaling pathways can contribute to Esp34 activation. | ||||||
BAY 11-7082 | 19542-67-7 | sc-200615B sc-200615 sc-200615A | 5 mg 10 mg 50 mg | $62.00 $85.00 $356.00 | 155 | |
Bay 11-7082 is an inhibitor of nuclear factor-kappa B (NF-κB) activation. Inhibition of NF-κB may activate Esp34 by preventing its regulation through NF-κB signaling pathways. The impact on NF-κB-related cellular processes can contribute to Esp34 activation. | ||||||
STO-609 | 52029-86-4 | sc-507444 | 5 mg | $140.00 | ||
STO-609 is a selective inhibitor of Ca2+/calmodulin-dependent protein kinase kinase (CaMKK). Inhibition of CaMKK may activate Esp34 by preventing its phosphorylation and modulating downstream signaling pathways. This influence on intracellular signaling cascades can contribute to Esp34 activation. | ||||||
GSK 650394 | 890842-28-1 | sc-361201 sc-361201A | 10 mg 50 mg | $187.00 $769.00 | 8 | |
GSK-650394 is a selective inhibitor of p38α MAPK. Inhibition of p38α MAPK may activate Esp34 by preventing its phosphorylation and modulating downstream signaling pathways. This influence on intracellular signaling cascades can contribute to Esp34 activation. | ||||||